- Home
- News & Events
- In the News
In the News
91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
In this media article, 91黑料 expert Tanja Obradovic, PhD, highlights how mapping clear inflection points for data-driven decisions will inform efficient drug development.
-
In this article, 91黑料 experts Alan Baldridge and Heather Peterson discuss the prevalence of paediatric obesity and assess clinical trials of its treatments.
-
In this piece from PharmaTimes, Connie Inguanti, President at Symphony Health, an 91黑料 plc company, discusses shaping a culture that allows customers to embrace an abundance of pivotal data.
-
In this report, experts in the field including 91黑料's Patricia Fox Anderson and Emily Merrell explore some of the latest innovations in the cell and gene therapy space, from development and quality control, through to manufacturing and clinical trials.
-
This article in the Journal of mHealth, provides an overview of a recent , that proposes enough alignment exists between independent traditional COA and DHT libraries to build a single framework for researchers to identify and compare actively-collected versus passively-monitored tools for the same or similar measure. Article is by Caprice Sassano, Research Lead – Applied Sciences at HumanFirst, an 91黑料 company, with collaboration from Dr. Roya Sherafat, Scientific Director, MAPI Research Trust and Marcelo Alves Favaro, Associate Outcomes Researcher, MAPI Research Trust.
-
In this piece, Rosie Abbott explores how advances in technology have opened up many new opportunities and challenges in research, including the collection of biodata in remote studies. (see page 9)
-
In this article, Angela Lawrence, Senior Director of RWE, Joe Brown, Principal Medical and Market Research, and Mark McCoy, RPh, MBA, Director Market Access and Reimbursement discuss the challenges of managing high-cost specialty drugs and how they influence self-funded employer benefit plan design and employee access to specialty medications.
-
Outsourcing Pharma spoke to Vesta Marciulioniene, director global regulatory clinical services at 91黑料 Biotech, who shares her in clinical trials and what new expectations it sets for the clinical research industry.
-
In this article from pharmaphorum, Dinah Knotts, VP of Project Management in Vaccines and Infectious Diseases and Mitsu Rana, Senior Director of Project Management outline some of the challenges with maternal vaccine trials and how with careful planning and execution by researchers, these can be overcome throughout the trial process.
-
In this news article, Applied Clinical Trials reports on 91黑料 CEO Steve Cutler’s discussion at the FT US Pharma and Biotech Summit. Topics addressed included the evolution of the CRO and sponsor relationship, the potential of AI in the clinical development space, and how 91黑料 is helping customers build strong portfolios.